|
|
Previous Article | Table of Contents | Next Article 
Methylation of the Epstein-Barr Virus Genome in Normal Lymphocytes
Keith D. Robertson and
Richard F. Ambinder
From the Departments of Oncology, Pharmacology, and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD.
Epstein-Barr virus (EBV) latent infection in B cells persists over years or decades despite a sustained cytotoxic immune response to viral antigens. We present data that methylated EBV DNA can be detected in the normal lymphocytes of healthy volunteers. Whereas methylation of foreign DNA has been recognized as a potential cellular defense mechanism, methylation of EBV DNA may be an essential part of the virus life cycle in vivo, explaining the persistence of virus-infected B cells in the face of immune surveillance. Methylation of the C promoter helps to prevent expression of the immunodominant antigens expressed from this promoter. First recognized in tumors, methylation-associated evasion of immune surveillance is not an aberration restricted to tumor tissue but is detected in normal EBV-infected lymphocytes. Methylation of the viral genome in latency also provides an explanation for the CpG suppression associated with EBV but not other large DNA viruses.
Blood, Vol. 90 No. 11 (December 1), 1997:
pp. 4480-4484
© 1997 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Yoshioka, M. M. Crum, and J. T. Sample
Autorepression of Epstein-Barr Virus Nuclear Antigen 1 Expression by Inhibition of Pre-mRNA Processing
J. Virol.,
February 15, 2008;
82(4):
1679 - 1687.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Renaud, D. Loukinov, Z. Abdullaev, I. Guilleret, F. T. Bosman, V. Lobanenkov, and J. Benhattar
Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene
Nucleic Acids Res.,
February 28, 2007;
35(4):
1245 - 1256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-h. Feng and S. C. Kenney
Valproic Acid Enhances the Efficacy of Chemotherapy in EBV-Positive Tumors by Increasing Lytic Viral Gene Expression.
Cancer Res.,
September 1, 2006;
66(17):
8762 - 8769.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-K. Chang, J.-Y. Chung, Y.-R. Hong, T. Ichimura, M. Nakao, and S.-T. Liu
Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1
Nucleic Acids Res.,
November 28, 2005;
33(20):
6528 - 6539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Bhende, W. T. Seaman, H.-J. Delecluse, and S. C. Kenney
BZLF1 Activation of the Methylated Form of the BRLF1 Immediate-Early Promoter Is Regulated by BZLF1 Residue 186
J. Virol.,
June 15, 2005;
79(12):
7338 - 7348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Elliott, E. B. Goodhew, L. T. Krug, N. Shakhnovsky, L. Yoo, and S. H. Speck
Variable Methylation of the Epstein-Barr Virus Wp EBNA Gene Promoter in B-Lymphoblastoid Cell Lines
J. Virol.,
December 15, 2004;
78(24):
14062 - 14065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T.C. Chan, Q. Tao, K. D. Robertson, I. W. Flinn, R. B. Mann, B. Klencke, W. H. Kwan, T. W.-T. Leung, P. J. Johnson, and R. F. Ambinder
Azacitidine Induces Demethylation of the Epstein-Barr Virus Genome in Tumors
J. Clin. Oncol.,
April 15, 2004;
22(8):
1373 - 1381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yoshioka, H. Kikuta, N. Ishiguro, X. Ma, and K. Kobayashi
Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection
J. Gen. Virol.,
May 1, 2003;
84(5):
1133 - 1140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Tao, H. Huang, T. M. Geiman, C. Y. Lim, L. Fu, G.-H. Qiu, and K. D. Robertson
Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells
Hum. Mol. Genet.,
September 1, 2002;
11(18):
2091 - 2102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q N Vo, J Geradts, M L Gulley, D A Boudreau, J C Bravo, and B G Schneider
Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation
J. Clin. Pathol.,
September 1, 2002;
55(9):
669 - 675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Tierney, H. E. Kirby, J. K. Nagra, J. Desmond, A. I. Bell, and A. B. Rickinson
Methylation of Transcription Factor Binding Sites in the Epstein-Barr Virus Latent Cycle Promoter Wp Coincides with Promoter Down-Regulation during Virus-Induced B-Cell Transformation
J. Virol.,
November 15, 2000;
74(22):
10468 - 10479.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Krithivas, D. B. Young, G. Liao, D. Greene, and S. D. Hayward
Human Herpesvirus 8 LANA Interacts with Proteins of the mSin3 Corepressor Complex and Negatively Regulates Epstein-Barr Virus Gene Expression in Dually Infected PEL Cells
J. Virol.,
October 15, 2000;
74(20):
9637 - 9645.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. J. Jenkins, U. K. Binné, and P. J. Farrell
Histone Acetylation and Reactivation of Epstein-Barr Virus from Latency
J. Virol.,
January 1, 2000;
74(2):
710 - 720.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. J. Paulson and S. H. Speck
Differential Methylation of Epstein-Barr Virus Latency Promoters Facilitates Viral Persistence in Healthy Seropositive Individuals
J. Virol.,
December 1, 1999;
73(12):
9959 - 9968.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Chen, J. M. Lee, Y. Wang, D. P. Huang, R. F. Ambinder, and S. D. Hayward
The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity
PNAS,
August 3, 1999;
96(16):
9339 - 9344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Tao, L. J. Swinnen, J. Yang, G. Srivastava, K. D. Robertson, and R. F. Ambinder
Methylation Status of the Epstein-Barr Virus Major Latent Promoter C in Iatrogenic B Cell Lymphoproliferative Disease : Application of PCR-Based Analysis
Am. J. Pathol.,
August 1, 1999;
155(2):
619 - 625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Singal and G. D. Ginder
DNA Methylation
Blood,
June 15, 1999;
93(12):
4059 - 4070.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Tao, K. D. Robertson, A. Manns, A. Hildesheim, and R. F. Ambinder
The Epstein-Barr Virus Major Latent Promoter Qp Is Constitutively Active, Hypomethylated, and Methylation Sensitive
J. Virol.,
September 1, 1998;
72(9):
7075 - 7083.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |